Ondine Commencing US Phase 3 Clinical Trial

VANCOUVER, BC / ACCESSWIRE / December 17, 2024 / Ondine Biomedical Inc. (LON:OBI), a Canadian life sciences company pioneering...
22 hours ago
from: Accesswire

Clinical trial, Food and Drug Administration, Health care

More about this

- Ondine Biomedical Launches US Phase 3 Trial for Innovative Antimicrobial Technology
Ondine Biomedical, Inc. ( ($GB:OBI) ) has shared an update. Ondine Biomedical Inc. is set to commence a Phase 3 clinical trial in the US for...
from: TipRanks

- Ondine Biomedical to start phase three Steriwave clinical trial
Ondine Biomedical announced on Tuesday that it would begin its phase three 'LANTERN' clinical trial for its novel nasal photodisinfection...
from: Sharecast News